About the Analgesics Market
Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.
Technavio’s analysts forecast the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global analgesics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of analgesics globally. The report does not include revenue generated from the aftermarket service of the product.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Analgesics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.
Key vendors
• Pfizer
• Bayer HealthCare
• Sanofi
• Endo
• Johnson & Johnson
• Purdue Pharma
Other prominent vendors
• Achelios Therapeutics
• Alder BioPharmaceuticals
• Allergan
• Amgen
• AstraZeneca
• Baxter
• Boehringer Ingelheim
• Bristol Myers Squibb
• CoLucid Pharmaceuticals
• Daiichi Sankyo
• Dr. Reddy's Laboratories
• DURECT
• El Lilly & Company
• F. Hoffmann La Roche
• GlaxoSmithKline
• GW Pharmaceuticals
• Hospira
• Immune Pharmaceuticals
• Innovative Med Concepts
• Merck
• NeurAxon
• Novartis
• OptiNose
• Pain Therapeutics
• RedHill
• Sorrento Therapeutics
• Suda
• Taro Pharmaceuticals Industries
• Teva Pharmaceuticals Industries
• Tonix Pharmaceuticals
• Trigemina
• UCB
• Valeant Pharmaceuticals International
• WEX Pharmaceuticals
• Zynerba Pharmaceuticals
Market driver
• Increase in self-medication
• For a full, detailed list, view our report
Market challenge
• Preference for alternative therapies
• For a full, detailed list, view our report
Market trend
• Accelerated use of online resources
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Pain: Overview
PART 05: Pipeline portfolio
• Information on pipeline candidates
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by drug class
• Opioids
• NSAIDs
• Other
• Global opioids market
• Global NSAIDs Market
PART 08: Market segmentation by type
• Prescription analgesics
• OTC analgesics
PART 09: Market segmentation by application
• Global internal analgesics market
• Global external analgesics market
PART 10: Market segmentation by pain type
• Musculoskeletal pain
• Surgical and trauma pain
• Cancer pain
• Neuropathic pain
• Migraine
• Obstetrical pain
Fibromyalgia
• Pain due to burns
• Dental/facial pain
• Pediatric pain
PART 11: Market segmentation by ROA
• Oral
• Parenteral
• Topical
• Transdermal
• Rectal
PART 12: Geographical segmentation
• Analgesics market in Americas
• Analgesics market in EMEA
• Analgesics market in APAC
PART 13: Market drivers
• Growing geriatric population
• Increase in self-medication
• Promising pipeline
• Favorable regulatory scenario
PART 14: Impact of drivers
PART 15: Market challenges
• Generic competition
• Preference for alternative therapies
• Counterfeit pharmaceuticals
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Accelerated use of online resources
• Increase in R&D
• Off-label drugs use
• Strategic alliances
PART 18: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Pfizer
• Bayer Healthcare
• Sanofi
• Endo International
• Johnson & Johnson
• Purdue Pharma
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Pain assessment
Exhibit 03: Types of pain scales
Exhibit 04: Treatment options for pain
Exhibit 05: Commonly used non-opioids for pain
Exhibit 06: Commonly used adjuvant medicines for pain
Exhibit 07: Treatment algorithm for pain
Exhibit 08: Pipeline portfolio: Major analgesic candidates under development for pain
Exhibit 09: Global analgesics market 2015-2020 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Global analgesics market by drug class
Exhibit 12: Segmentation of global analgesics market by drug class 2015
Exhibit 13: Global analgesics market segmentation by drug class 2015-2020 ($ billions)
Exhibit 14: Global analgesics market segmentation by drug class 2015-2020
Exhibit 15: Global analgesics market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
Exhibit 16: Global opioids market 2015-2020 ($ billions)
Exhibit 17: Global NSAIDs market 2015-2020 ($ billions)
Exhibit 18: Global analgesics segmentation by type
Exhibit 19: Global analgesics segmentation by type 2015
Exhibit 20: Global analgesics market segmentation by type 2015-2020 ($ billions)
Exhibit 21: Global analgesics market segmentation by type 2015-2020
Exhibit 22: Global analgesics market: YoY revenue and growth based on type 2015-2020 ($ billions)
Exhibit 23: Global prescription analgesics market 2015-2020 ($ billions)
Exhibit 24: Global OTC analgesics market 2015-2020 ($ billions)
Exhibit 25: Global analgesics market segmentation by application
Exhibit 26: Global internal analgesics market 2015-2020 ($ billions)
Exhibit 27: Global external analgesics market 2015-2020 ($ billions)
Exhibit 28: Global analgesics market segmentation by application 2015-2020 ($ billions)
Exhibit 29: Global analgesics market segmentation by application 2015-2020
Exhibit 30: Global analgesics market: YoY revenue and growth based on application 2015-2020 ($ billions)
Exhibit 31: Global analgesics market segmentation by type
Exhibit 32: Global analgesics market segmentation by type 2015
Exhibit 33: Global analgesics market segmentation by ROA
Exhibit 34: Global analgesics market segmentation by ROA 2015
Exhibit 35: Global analgesics market by geography 2015
Exhibit 36: Global analgesics market revenue by geography 2015-2020 ($ billions)
Exhibit 37: Global analgesics market revenue by geography 2015-2020
Exhibit 38: Global analgesics market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 39: Analgesics market in Americas 2015-2020 ($ billions)
Exhibit 40: Analgesics market in EMEA 2015-2020 ($ billions)
Exhibit 41: Analgesics market in APAC 2015-2020 ($ billions)
Exhibit 42: Population aged 60 years and over: World, developed, and developing regions (millions)
Exhibit 43: Expected growth of older population in US 2010-2050
Exhibit 44: Impact of drivers
Exhibit 45: Alternative therapies for pain
Exhibit 46: Use of CAM therapies among individuals in US
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Global Internet penetration rate 2015
Exhibit 49: Market share analysis 2015
Exhibit 50: Revenue share of major companies for global analgesics market 2015
Exhibit 51: Revenues from the sales of top five analgesics 2013-2015 ($ millions)
Exhibit 52: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 53: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
Exhibit 54: Pfizer: YoY revenue and growth rate of Relpax 2013-2015 ($ millions)
Exhibit 55: Pfizer: Key takeaways
Exhibit 56: Bayer HealthCare: YoY revenue and growth rate of Aspirin 2013-2015 ($ millions)
Exhibit 57: Bayer HealthCare: YoY revenue and growth rate of Aleve 2013-2015 ($ millions)
Exhibit 58: Bayer HealthCare: Key takeaways
Exhibit 59: Sanofi: YoY revenue and growth rate of Doliprane 2013-2015 ($ millions)
Exhibit 60: Sanofi: YoY revenue and growth rate of Dorflex 2013-2015 ($ millions)
Exhibit 61: Sanofi: YoY revenue and growth rate of Synvisc/Synvisc One 2013-2015 ($ millions)
Exhibit 62: Sanofi: YoY revenue and growth rate of No Spa 2013-2015 ($ millions)
Exhibit 63: Sanofi: Key takeaways
Exhibit 64: Endo International: YoY revenue and growth rate of Opana ER 2013-2015 ($ millions)
Exhibit 65: Endo International: YoY revenue and growth rate of Voltaren 2013-2015 ($ millions)
Exhibit 66: Endo International: YoY revenue and growth rate of Lidoderm 2013-2015 ($ millions)
Exhibit 67: Endo International: YoY revenue and growth rate of Percocet 2013-2015 ($ millions)
Exhibit 68: Endo International: Key takeaways
Exhibit 69: Johnson & Johnson: Key takeaways
Exhibit 70: Purdue Pharma: Key takeaways
